BPC-157 (Spray)
Body Protection Compound (Nasal)
CAS: 137525-51-0
Formula: C62H98N16O22
M.W.: 1419.5347 g/mol
Purity: 99%+ HPLC Verified
Ref No.: BPC-0030SP
For Research Use Only (RUO)
Not for human or veterinary use.
BPC-157 (Spray)
Category
Regenerative Research
CAS Number
137525-51-0
Form Factor
Nasal Spray
In stock, ready to ship
Ships same day before 12pm PST
Products are shipped in nasal spray form.
BPC-157 intranasal formulations are investigated in experimental models to characterize mucosal permeability, absorption kinetics, systemic biodistribution, and potential olfactory or trigeminal transport pathways. Research parameters include angiogenic signaling, growth-factor expression, nitric oxide pathway activity, peptide stability, and formulation-dependent transport characteristics.
Description
BPC-157 intranasal formulations are investigated in experimental models to characterize mucosal permeability, absorption kinetics, systemic biodistribution, and potential olfactory or trigeminal transport pathways. Research parameters include angiogenic signaling, growth-factor expression, nitric oxide pathway activity, peptide stability, and formulation-dependent transport characteristics.Chemical Information
CAS Number
137525-51-0
Purity
99%+ HPLC Verified
Molecular Formula
C62H98N16O22
Molar Mass
1419.5347 g/mol
Form Factor
Nasal Spray
Synonyms
Research Applications
- Intranasal Transport Research: BPC-157 formulations are evaluated in experimental models to characterize peptide transport across vascularized nasal mucosa. Research parameters include absorption kinetics, systemic distribution, first-pass metabolic avoidance, and potential olfactory or trigeminal transport pathways to the central nervous system.
- Neuroscience Research: Intranasal BPC-157 is studied to characterize potential nose-to-brain transport and CNS biodistribution. Investigations compare intranasal and systemic delivery models, focusing on peptide localization, neurobiological signaling, and experimental models of neural injury.
- Pharmaceutical Sciences: BPC-157 intranasal formulations are examined through physicochemical and delivery-system characterization. Research endpoints include droplet or particle-size distribution, mucosal retention, excipient compatibility, peptide integrity, and formulation stability.
- Systemic Signaling Research: Experimental studies assess whether intranasal exposure to BPC-157 influences angiogenic and tissue-remodeling pathways beyond the delivery site. Comparative models evaluate molecular signaling and regenerative-response markers associated with intranasal and subcutaneous delivery methods.
Storage Conditions
Unreconstituted
Store at -20°C to 4°C (freezer or refrigerator). Stable for 24+ months.
Reconstituted
Refrigerate at 2–8°C. Use within 30 days for optimal stability.
Avoid
Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C.
Safety & Compliance
- Wear nitrile gloves and safety goggles when handling research compounds.
- Work in a clean, controlled environment (laminar flow hood recommended).
- Dispose of sharps and used materials in approved biohazard containers.
- This product is for laboratory research use only (RUO) — not for human or veterinary use.
Quality Assurance Standards
Each production lot is subjected to rigorous analytical evaluation to meet pharmaceutical-grade specifications. Full testing results and procedural documentation are furnished through the accompanying Certificate of Analysis (COA) with every shipment.
Certificate of Analysis
Latest COA for BPC-157 (Spray) — independently tested via HPLC and Mass Spectrometry.
Testing Methodology
Every batch undergoes a multi-stage analytical pipeline before release. Results are compiled into the Certificate of Analysis (COA) included with each order.
- • HPLC — High-Performance Liquid Chromatography confirms peptide purity ≥98%.
- • Mass Spectrometry — Validates molecular identity and correct sequence.
- • Endotoxin (LAL) — Limulus Amebocyte Lysate assay ensures endotoxin levels are within safe limits.
- • Sterility — Microbial contamination testing per USP standards.
Learn More About Peptides
Explore our research library covering purity, synthesis, storage, solubility, and more.
Research Database
Browse peer-reviewed studies, clinical trials, and scientific sources behind our peptide resources.
You May Also Like
-
$124.99
Semax (Spray)
GH / Neuro / Misc ResearchThis product has multiple variants. The options may be chosen on the product page View Details -
$99.99
NAD+ (Spray)
GH / Neuro / Misc ResearchThis product has multiple variants. The options may be chosen on the product page View Details -
$124.99
Selank (Spray)
GH / Neuro / Misc ResearchThis product has multiple variants. The options may be chosen on the product page View Details -
$109.99
PT-141 (Spray)
GH / Neuro / Misc ResearchThis product has multiple variants. The options may be chosen on the product page View Details
Popular Product
Popular Product
Popular Product
Popular Product
Description
BPC-157 intranasal formulations are investigated in experimental models to characterize mucosal permeability, absorption kinetics, systemic biodistribution, and potential olfactory or trigeminal transport pathways. Research parameters include angiogenic signaling, growth-factor expression, nitric oxide pathway activity, peptide stability, and formulation-dependent transport characteristics.Chemical Information
CAS Number
137525-51-0
Purity
99%+ HPLC Verified
Molecular Formula
C62H98N16O22
Molar Mass
1419.5347 g/mol
Form Factor
Nasal Spray
Synonyms
Research Applications
- Intranasal Transport Research: BPC-157 formulations are evaluated in experimental models to characterize peptide transport across vascularized nasal mucosa. Research parameters include absorption kinetics, systemic distribution, first-pass metabolic avoidance, and potential olfactory or trigeminal transport pathways to the central nervous system.
- Neuroscience Research: Intranasal BPC-157 is studied to characterize potential nose-to-brain transport and CNS biodistribution. Investigations compare intranasal and systemic delivery models, focusing on peptide localization, neurobiological signaling, and experimental models of neural injury.
- Pharmaceutical Sciences: BPC-157 intranasal formulations are examined through physicochemical and delivery-system characterization. Research endpoints include droplet or particle-size distribution, mucosal retention, excipient compatibility, peptide integrity, and formulation stability.
- Systemic Signaling Research: Experimental studies assess whether intranasal exposure to BPC-157 influences angiogenic and tissue-remodeling pathways beyond the delivery site. Comparative models evaluate molecular signaling and regenerative-response markers associated with intranasal and subcutaneous delivery methods.
Storage Conditions
Unreconstituted
Store at -20°C to 4°C (freezer or refrigerator). Stable for 24+ months.
Reconstituted
Refrigerate at 2–8°C. Use within 30 days for optimal stability.
Avoid
Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C.
Safety & Compliance
- Wear nitrile gloves and safety goggles when handling research compounds.
- Work in a clean, controlled environment (laminar flow hood recommended).
- Dispose of sharps and used materials in approved biohazard containers.
- This product is for laboratory research use only (RUO) — not for human or veterinary use.
Quality Assurance Standards
Each production lot is subjected to rigorous analytical evaluation to meet pharmaceutical-grade specifications. Full testing results and procedural documentation are furnished through the accompanying Certificate of Analysis (COA) with every shipment.
Certificate of Analysis
Latest COA for BPC-157 (Spray) — independently tested via HPLC and Mass Spectrometry.
Testing Methodology
Every batch undergoes a multi-stage analytical pipeline before release. Results are compiled into the Certificate of Analysis (COA) included with each order.
- • HPLC — High-Performance Liquid Chromatography confirms peptide purity ≥98%.
- • Mass Spectrometry — Validates molecular identity and correct sequence.
- • Endotoxin (LAL) — Limulus Amebocyte Lysate assay ensures endotoxin levels are within safe limits.
- • Sterility — Microbial contamination testing per USP standards.
Learn More About Peptides
Explore our research library covering purity, synthesis, storage, solubility, and more.
Research Database
Browse peer-reviewed studies, clinical trials, and scientific sources behind our peptide resources.
